Life Sciences Research, Inc. LSRI (fka LSRI)

[savin4college]

Q2 Results Rock!!!! (August 5)

...revenues for the Q2 '04 were $38.3 million, operating profit was $4.0 million, or 10.4% of revenues, and EBITDA excluding foreign exchange remeasurement gains associated with the Company's Bonds was $6.3 million, or 16.4% of revenues. Each of these represents an improvement on the quarter ended March 31, 2004 which in turn were at the highest level for five years when announced.

LSRI qualifies for Nasdaq in all respects other than its share price needs to trade for 90 days above (I believe) $5.00; it seems we're about 40/45 days into that wait!

Really worth a closer look; this is the real deal

S4C